Isolated polypeptide deletion mutants of survival of motor neuron-interacting protein 1
View Patent ↗The invention relates to an isolated nucleic acid encoding a eukaryotic Survival of Motor Neuron-Interacting Protein 1 (SIP1), compositions comprising SIP1 and SIP1 and the spinal muscular atrophy (SMA) disease gene product Survival of Motor Neuron protein (SMN), and diagnostic and therapeutic assays directed to SMA. The invention also relates to another protein that specifically interacts with SMN and is a component of gems, designated Gemin3, and the nucleic acid encoding the protein. Additionally, the invention relates to a novel cell line wherein the endogenous SMN genes have been deleted and where an exogenous nucleic acid encoding SMN has been inserted into the cell such that expression of SMN in the cell is under the control of an inducible promoter. This novel cell line provides a stable genetic system for the study of SMA and for the development of SMA therapeutics.
1. An isolated nucleic acid encoding a human Survival of Motor Neuron-Interacting Protein 1, wherein said nucleic acid encodes a polypeptide comprising SEQ ID NO: 2 that differs from the amino acid sequence of SEQ ID NO: 2 by a mutation that inhibits binding of Survival Motor Neuron-Interacting Protein 1 with Survival Motor Neuron protein, wherein said mutation is selected from the group consisting of a deletion of the carboxyl terminal 89 amino acids relative to the amino acid sequence of SEQ ID NO: 2 and a deletion of the carboxyl terminal 162 amino acids relative to the amino acid sequence of SEQ ID NO: 2, and further wherein said nucleic acid comprises a nucleic acid encoding a tag polypeptide covalently linked thereto.
2. The isolated nucleic acid of claim 1 , said nucleic acid further comprising a nucleic acid encoding a promoter/regulatory sequence operably linked thereto.
3. A vector comprising the isolated nucleic acid of claim 1 .
4. The vector of claim 3 , said vector further comprising a nucleic acid encoding a promoter/regulatory sequence operably linked thereto.
5. An isolated recombinant cell comprising the vector of claim 3 .
6. An isolated recombinant cell comprising the isolated nucleic acid of claim 1 .
7. An antisense isolated nucleic acid complementary to the nucleic acid of claim 1 .
8. An isolated recombinant cell comprising the antisense nucleic acid of claim 7 .